Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.91% | 195.59 | 1.2% | $518.97m | |
| GILD | Gilead Sciences, Inc. | -1.10% | 72.78 | 0.9% | $459.77m | |
| BIIB | Biogen Inc. | -0.76% | 328.41 | 1.3% | $384.66m | |
| CELG | Celgene Corporation | -0.91% | 81.83 | 1.2% | $339.18m | |
| ILMN | Illumina, Inc. | -2.57% | 313.41 | 3.5% | $297.65m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.72% | 377.55 | 2.6% | $228.49m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.37% | 121.49 | 2.0% | $215.08m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -2.02% | 177.65 | 1.9% | $210.48m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.64% | 131.34 | 16.4% | $171.12m | |
| A | Agilent Technologies, Inc. | -0.92% | 65.63 | 1.5% | $157.48m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.06% | 99.45 | 4.4% | $135.37m | |
| LGND | Ligand Pharmaceuticals Incorporated | -1.24% | 200.07 | 23.3% | $115.36m | |
| VKTX | Viking Therapeutics, Inc. | -1.80% | 14.20 | 0.9% | $112.03m | |
| NKTR | Nektar Therapeutics | 0.35% | 49.08 | 5.6% | $109.05m | |
| EXAS | Exact Sciences Corporation | -2.16% | 65.77 | 25.3% | $103.02m |
Company Profile
Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which treat catcer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. Its products pipeline include JTX-2011 (ICOS); JTX-4014 (PD-1); Lead Macrophage Program; Macrophage Targeting; T Reg; B Cells; and Stromal Targeting. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharmain in 2013 and is headquartered in Cambridge, MA.